Litigation Details for NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)
✉ Email this page to a colleague
NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)
| Docket | ⤷ Subscribe | Date Filed | 2023-06-05 |
| Court | District Court, District of Columbia | Date Terminated | 2023-12-04 |
| Cause | 05:702 Administrative Procedure Act | Assigned To | Randolph Daniel Moss |
| Jury Demand | None | Referred To | |
| Patents | 10,314,828; 10,335,397; 10,456,384; 6,861,053; 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,642,573; 8,741,904; 8,829,017; 8,835,452; 8,853,231; 8,946,252; 8,969,398; 9,271,968; 9,421,195; 9,623,001; 9,629,828 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in NORWICH PHARMACEUTICALS, INC. v. BECERRA
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe and ⤷ Subscribe .
Details for NORWICH PHARMACEUTICALS, INC. v. BECERRA (D.D.C. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-06-05 | 1 | Exhibit 1 | (the 9'828 patent) July 24, 2029 10,314,828 (the 4'828 patent) July 24, 2029 …550 mg, is subject to periods of patent protection. The following patents and expiration dates are currently… U.S. Patent Number Expiration Date 7,045,620 (the '620 patent) June…7,612,199 (the '199 patent) June 19, 2024 7,902,206 (the '206 patent) June 19, 2024…7,906,542 (the '542 patent) June 1, 2025 7,915,275 (the '275 patent) February 23, | External link to document |
| 2023-06-12 | 12 | Exhibit Complaint | (last visited Jun. 4, 2023). 10 U.S. Patent Nos. 10,314,828; 10,335,397; 10,456,384; 7,045,620; 7,612,199… “Asserted HE Patents” refers to claim 8 of U.S. Patent No. 8,642,573 (the “’573 Patent”), claim 6 of …of U.S. Patent No. 9,421,195 (the “’195 Patent”), and claims 11-12 of U.S. Patent No. 10,335,397 (the “…claims from three asserted method of use patents (“the HE Patents”), and that Norwich’s Original ANDA should…Amended ANDA contain a Paragraph IV patent certification to any patent held to have been infringed under | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
